Bleichroeder’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
Other funds holding CUE
Bleichroeder's CUE Position: Q3 2026 in Review
Bleichroeder reduced its Cue Biopharma (CUE) stake by 1.2% in Q3 2026, selling an estimated $134K and leaving 366,152 shares worth $9.47M. The position accounts for 0.93% of the portfolio, ranked #41.
Bleichroeder first reported a position in CUE in Q4 2019 and has held it in 28 quarters since. The position peaked at $11.7M in Q2 2026. 37 funds tracked by Wall St. Rank hold CUE as of Q3 2026.
- Bleichroeder held 366,152 shares of Cue Biopharma worth $9.47M as of Q3 2026.
- Bleichroeder sold 4,530 Cue Biopharma shares in Q3 2026, an estimated $134K.
- Cue Biopharma made up 0.93% of Bleichroeder's portfolio in Q3 2026, its #41 holding.
- Bleichroeder first reported a position in Cue Biopharma in Q4 2019 and has held it in 28 quarters since.
- Bleichroeder's Cue Biopharma position peaked at $11.7M in Q2 2026.
- 37 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2026.
Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.